Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 09-2008 | 06-2008 | 03-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,186 | 19,695 | 35,420 | 25,985 | 10,423 |
| Marketable Securities | 63,127 | 83,946 | 77,492 | 79,657 | 120,000 |
| Receivables | 1,337 | 6,832 | 4,209 | 1,607 | 1,995 |
| Other current assets | 3,531 | 2,789 | 3,060 | 3,378 | 3,111 |
| TOTAL | $124,181 | $113,262 | $120,181 | $110,627 | $135,529 |
| Non-Current Assets | |||||
| PPE Net | 11,071 | 12,104 | 12,840 | 13,194 | 13,511 |
| Investments And Advances | 22,061 | 30,953 | 37,653 | 49,326 | 39,947 |
| Other Non-Current Assets | 520 | 526 | 527 | 553 | 552 |
| TOTAL | $33,652 | $43,583 | $51,020 | $63,073 | $54,010 |
| Total Assets | $157,833 | $156,845 | $171,201 | $173,700 | $189,539 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,496 | 11,416 | 12,993 | 12,696 | 14,765 |
| Other current liabilities | 57 | 57 | 57 | 57 | 57 |
| TOTAL | $38,198 | $25,650 | $27,190 | $28,888 | $32,550 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 31,645 | 14,177 | 14,140 | 16,135 | 17,728 |
| Other Non-Current Liabilities | 266 | 290 | 313 | 336 | 359 |
| TOTAL | $266 | $3,123 | $5,203 | $6,962 | $9,490 |
| Total Liabilities | $38,464 | $28,773 | $32,393 | $35,850 | $42,040 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,782 | 30,456 | 30,454 | 30,022 | 29,847 |
| Common Shares | 40 | 40 | 39 | 39 | 39 |
| Retained earnings | -298,718 | -284,120 | -271,900 | -269,531 | -254,046 |
| Other shareholders' equity | -1,038 | -2,391 | -489 | 392 | 6 |
| TOTAL | $119,369 | $128,072 | $138,808 | $137,850 | $147,499 |
| Total Liabilities And Equity | $157,833 | $156,845 | $171,201 | $173,700 | $189,539 |